Latest / IMA (Formerly FLCCC Alliance)
#268 (Sep. 30, 2026) 'Moderna’s mRNA Flu Shot Under Scrutiny' IMA (formerly FLCCC) Weekly Update
Sign up for weekly webinars: https://imahealth.org/weekly-webinars/ign up for weekly webinars: Weekly Webinars - Independent Medical Alliance
What does the data show when Moderna’s mRNA flu vaccine is evaluated using absolute measures of benefit and risk?
IMA President and Chief Medical Officer Dr. Joseph Varon was joined by Dr. Peter McCullough, Nicolas Hulscher, and Dr. John Catanzaro to examine their new reanalysis of FDA clinical trial data for Moderna’s mFLUSIVA (mRNA-1010).
They discussed:
• The vaccine’s reported efficacy and absolute clinical benefit
• Adverse reactions and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.